Clinical Trials Browser

Completed × INDUSTRY × Solid Tumor, Adult × Clear all

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2025-08-28

EPRAD

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04105335 2025-03-06

TIMEPOINT

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT03516123 2024-09-19

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05117177 2024-09-19

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05054348 2024-06-04

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05309187 2024-06-04

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04683354 2023-02-13

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04428086 2022-07-26

A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03951116 2022-03-16

FCN-437c

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03673020 2021-12-02

Phase 1a Study to Evaluate Immunogenicity of ASV®

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03147378 2021-10-19

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03360734 2021-07-12

GATTO

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04515043 2021-06-01

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03008018 2020-08-19

HDAC6i

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult